| P2093 | author name string | Taatjes DJ | |
| | Sobel BE | |
| | Schneider DJ | |
| | Howard DB | |
| P2860 | cites work | Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 |
| | Platelet alpha-granule fibrinogen, albumin, and immunoglobulin G are not synthesized by rat and mouse megakaryocytes | Q34262399 |
| | Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules | Q34576457 |
| | Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets | Q35816269 |
| | Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules | Q35823997 |
| | Possible role of cytomegalovirus in atherogenesis | Q37875443 |
| | Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 |
| | Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 |
| | Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study | Q41300471 |
| | Relation of Helicobacter pylori infection and coronary heart disease | Q41333642 |
| | Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies | Q43950275 |
| | The effect of physiological levels of fibrinogen on platelet aggregation | Q44676091 |
| | Acute phase reaction, fibrinogen level and thrombus size | Q47174025 |
| | Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 |
| | Platelet procoagulant complex assembly in a tissue factor-initiated system | Q61405846 |
| | The influence of therapeutic blocking of Gp IIb/IIIa on platelet alpha-granular fibrinogen | Q67987420 |
| | Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 |
| | Optimally functional fluorescein isothiocyanate-labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation | Q71028494 |
| | Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 |
| | Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy | Q72133331 |
| | Differential effects of anticoagulants on the activation of platelets ex vivo | Q73914766 |
| | [Rapid physiological coagulation method in determination of fibrinogen] | Q74515389 |
| | Coagulability of the blood in ischaemic heart-disease | Q74613964 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 261-266 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk | |
| P478 | volume | 33 | |